ZEPOSIA caps 0.92 mg 28 pce

7680670460026 CH-67046 L04AE02 01.99.0.

Reimbursement limitations:

ZEPOSIA.01

Traitement de la sclérose en plaques (SEP) récurrente-rémittente. Première prescription par un spécialiste en neurologie …

ZEPOSIA caps 0.92 mg 28 pce
ZEPOSIA caps 0.92 mg 28 pce
ZEPOSIA caps 0.92 mg 28 pce
1 / 3
google

Details

Product number
6704603
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
ozanimodum 0.92 mg ut ozanimodi hydrochloridum 1 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 0.187 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Zeposia 0.92 mg, Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/06/2025
Patient information leaflet
Français
10/06/2025
Patient information leaflet
Italien
10/06/2025
Professional SmPC
Allemand
07/05/2025
Professional SmPC
Français
07/05/2025
Professional SmPC
Italien
07/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.92 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 1295.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2020

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
67046
Drug name
Zeposia, Hartkapseln
Galenic form
KAHA
ATC Code
L04AE02
Authorization status
Z
Dispensation category
B
First authorization
11/08/2020
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose, Colitis Ulcerosa

Packaging details

Description (FR)
ZEPOSIA caps 0.92 mg 28 pce
Description (DE)
ZEPOSIA Kaps 0.92 mg 28 Stk
Market launch
11/08/2020
Narcotic (BTM)
No

Other packaging sizes

ZEPOSIA emb départ caps 4x0.23mg 3x0.46mg 7 pce
1 KOMB
View